The National Agency for the Safety of Medicines and Health Products (ANSM) has ended the marketing of the nasal spray against Covid-19 "Previdspray".
"The clinical data are not sufficient to justify use against Covid-19", indicates the authority in a press release issued this Friday, May 6.
"As a result, the marketing of this product in pharmacies or any other place in France is stopped," she adds.
#Covid19: after a market surveillance action by the #ANSM, the marketing of the nasal spray Previdspray is stopped
The clinical data are not sufficient to justify use against Covid-19
➕information: https://t .co/OrvPl5Au32 pic.twitter.com/3mWeO2h87m
– ANSM (@ansm) May 6, 2022
Access to this content has been blocked to respect your choice of consent
By clicking on "
I ACCEPT
", you accept the deposit of cookies by external services and will thus have access to the content of our partners
I ACCEPT
And to better remunerate 20 Minutes, do not hesitate to accept all cookies, even for one day only, via our "I accept for today" button in the banner below.
More information on the Cookie Management Policy page.
The spray from a company based in Belgium
This spray is manufactured by Clers Medical, registered in Belgium.
The ANSM therefore asked the Belgian Federal Agency for Medicines and Health Products (FAMHP) "to carry out investigations on this product", can we read in the press release.
The technical documents of the product did not convince the health authorities.
"In accordance with the request of the FAMHP, the company Clers Medical is required to withdraw the batches of these devices", indicates the ANSM.
People who still have the "Previdspray" against Covid-19 are invited to throw it away.
Health
Coronavirus: The marketing of the “Cov-Defense” nasal spray suspended
Health
Covid-19: A prescription will now suffice to obtain Paxlovid quickly
Health
Covid-19
Coronavirus
Medication
Treatment